prednisolone has been researched along with Abdominal Obesity in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
" Univariate and multivariate analysis showed that higher numbers of system or organ involvement in SLE, abdominal obesity, hypertriglyceridemia and daily prednisolone of ≥ 1 mg/kg/day were the important associated factors of SDM (P ≤ 0." | 3.81 | Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort. ( Gafor, AH; Kong, NC; Said, MS; Shaharir, SS, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shaharir, SS | 1 |
Gafor, AH | 1 |
Said, MS | 1 |
Kong, NC | 1 |
1 other study available for prednisolone and Abdominal Obesity
Article | Year |
---|---|
Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; China; Cohort Studies; Cross-Sectional Studies | 2015 |